Samsung Bioepis Co., Ltd.
Overview
Samsung Bioepis Co., Ltd. is a biopharmaceutical company focused on developing and manufacturing biosimilar medicines. As a subsidiary of Samsung Biologics, it leverages cutting-edge technology to improve patient access to affordable and high-quality therapies.
Therapeutic areas
FDA compliance signals
1 FDA enforcement record linked to this company.
- recall — Class II2025-11-05
Lack of Assurance of Sterility.
Related companies
Boehringer Ingelheim International GmbH
Germany
Dompé Farmaceutici S.p.A.
Italy
Eli Lilly and Company
United States
F. Hoffmann-La Roche AG
Switzerland
F. Hoffmann-La Roche AG / Chugai Pharmaceutical Co., Ltd.
Switzerland
Genentech, Inc.
United States
Hoffmann-La Roche Inc.
Switzerland
Huadong Medicine Co., Ltd.
China
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.